Monday, 21 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14455
Articles
Company
Drug
Astellas Launches Late-Stage Trial in Japan for Nonhormonal Menopause Treatment
October 20, 2024
Policy / Regulatory
Hebei Province Proposes Measures for ‘Internet+’ Medical Services and Insurance Management
October 20, 2024
Company
Maruho Expands into China with New Wholly Owned Subsidiary in Beijing
October 20, 2024
Company
Drug
Sino-US Laekna’s LAE102 Clinical Trial Filing Accepted for Review in Obesity and Metabolic Disorders
February 10, 2025
Company
Deals
Haihe Pharmaceuticals Licenses Glumetinib to Taiho for Exclusive Development in Japan and Asia
October 20, 2024
Company
Deals
CANbridge Pharmaceuticals Partners with Peking Union Medical College to Advance Rare Disease Research
October 20, 2024
Company
Drug
Fosun Pharmaceutical Secures NMPA Approval for Phase II Study of FCN-338 and FCN-647 in Chronic Lymphocytic Leukemia
October 20, 2024
Company
Drug
Shanghai Pharmaceuticals’ MediTrust Health Teams Up with Eisai to Enhance Alzheimer’s Prevention and Treatment
October 20, 2024
Company
Drug
Fosun Pharmaceutical’s HanDaYuan Seeks NMPA Approval for Expanded Indications in Autoimmune Treatments
March 7, 2025
Policy / Regulatory
CDE Streamlines Patent Dispute Resolution for Generic Drug Filings with New Online Submission Process
October 20, 2024
Company
Drug
Jiangsu Hengrui Receives NMPA Approval for HRS-1167 Clinical Trials in Advanced Solid Tumors
December 3, 2024
Company
Drug
Innovent Biologics Launches Phase I Study for IBI3002, a Bispecific Antibody Targeting Asthma
October 20, 2024
1
2
…
754
755
756
757
758
…
1,204
1,205
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?